We are analyzing https://link.springer.com/article/10.1007/s11626-997-0048-8.

Title:
Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty | In Vitro Cellular & Developmental Biology - Animal
Description:
A chemically defined culture medium was developed to support the growth of two distinctly different types of normal human breast epithelial cells (HBEC) derived from reduction mammoplasty. Type I cells expressed luminal epithelial cell markers and were deficient in gap junctional intercellular communication (GJIC), whereas Type II cells expressed basal epithelial cell markers and were efficient in GJIC. In this study, we examined and compared the growth factor and hormone requirements of these two types of cells and a series of cell lines that were obtained by sequential transfection with SV40 DNA (extended lifespan, nontumorigenic), treatment with 5-bromodeoxyuridine (BrdU)/black light (immortal and weakly tumorigenic), and infection of a virus carrying the neu oncogene (highly tumorigenic). Growth of Type I cells was inhibited by withdrawing epidermal growth factor (EGF), hydrocortisone (HC), or insulin (INS) from the culture media, but was enhanced by fetal bovine serum (FBS) supplementation. Growth of Type II cells was inhibited by withdrawal of EGF, HC, or INS from the media, and was inhibited by FBS supplementation. Withdrawal of human transferrin (HT) or 17β-estradiol (E2) from the media did not alter the growth of Type I or Type II cells. SV40 transfected Type I cell lines still required EGF, HC, or INS for optimal growth. However, the highly tumorigenic cell line did not show a growth dependence on EGF, HC, or INS but did appear to require HT and 3,3′,5-triiodo-D.L. thyronine (T3) for optimal growth. In addition, FBS stimulated the growth of these cell lines. Thus, this study shows that Type I HBEC are distinctly different from Type II HBEC in growth response to FBS and that neoplastically transformed Type I cells could become growth factor and hormone independent.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Business & Finance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cells, article, google, scholar, human, pubmed, cas, epithelial, growth, cell, breast, mammary, normal, cancer, culture, type, natl, vitro, proc, sci, usa, types, access, res, acad, content, chang, factor, privacy, cookies, transformation, derived, differentiation, lines, virus, immortalization, media, publish, search, requirements, reduction, mammoplasty, kao, oakley, medium, inhibited, egf, ins, fbs, response,

Topics {✒️}

bypass stress-induced stasis month download article/chapter early-lactation human milk cell-type specific behaviour van der haegen sv40 large t-antigen supports long-term growth human cell line serum-free serial culture chinese hamster cells normal human breast luminal epithelial cells human mammary gland michigan state university differential proliferative response full article pdf breast cancer res type ii cells serum-free growth myeloproliferative sarcoma virus somatic cell genet article kao privacy choices/manage cookies neoplastically transformed type pleural effusion derived human skin keratinocytes fetal bovine serum related subjects epithelial cells pediatrics/human development growth factor requirements breast cancer myoepithelial cells isolated cell lines check access instant access rapid clonal growth sv40 transfected type myoepithelial-cell differentiation growth factor control main content log growth factors breast carcinoma european economic area reconstituted cutaneous environment extended serial passage thymidylate synthetase gene quantitative mutation marker type ii hbec single-step transformation

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty
         description:A chemically defined culture medium was developed to support the growth of two distinctly different types of normal human breast epithelial cells (HBEC) derived from reduction mammoplasty. Type I cells expressed luminal epithelial cell markers and were deficient in gap junctional intercellular communication (GJIC), whereas Type II cells expressed basal epithelial cell markers and were efficient in GJIC. In this study, we examined and compared the growth factor and hormone requirements of these two types of cells and a series of cell lines that were obtained by sequential transfection with SV40 DNA (extended lifespan, nontumorigenic), treatment with 5-bromodeoxyuridine (BrdU)/black light (immortal and weakly tumorigenic), and infection of a virus carrying the neu oncogene (highly tumorigenic). Growth of Type I cells was inhibited by withdrawing epidermal growth factor (EGF), hydrocortisone (HC), or insulin (INS) from the culture media, but was enhanced by fetal bovine serum (FBS) supplementation. Growth of Type II cells was inhibited by withdrawal of EGF, HC, or INS from the media, and was inhibited by FBS supplementation. Withdrawal of human transferrin (HT) or 17β-estradiol (E2) from the media did not alter the growth of Type I or Type II cells. SV40 transfected Type I cell lines still required EGF, HC, or INS for optimal growth. However, the highly tumorigenic cell line did not show a growth dependence on EGF, HC, or INS but did appear to require HT and 3,3′,5-triiodo-D.L. thyronine (T3) for optimal growth. In addition, FBS stimulated the growth of these cell lines. Thus, this study shows that Type I HBEC are distinctly different from Type II HBEC in growth response to FBS and that neoplastically transformed Type I cells could become growth factor and hormone independent.
         datePublished:
         dateModified:
         pageStart:282
         pageEnd:288
         sameAs:https://doi.org/10.1007/s11626-997-0048-8
         keywords:
            growth factors
            hormones
            differential serum response
            Cell Biology
            Developmental Biology
            Stem Cells
            Cell Culture
            Animal Genetics and Genomics
         image:
         isPartOf:
            name:In Vitro Cellular & Developmental Biology - Animal
            issn:
               1543-706X
               1071-2690
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Chien-Yuan Kao
               affiliation:
                     name:College of Human Medicine, Michigan State University
                     address:
                        name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cory S. Oakley
               affiliation:
                     name:College of Human Medicine, Michigan State University
                     address:
                        name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Clifford W. Welsch
               affiliation:
                     name:College of Human Medicine, Michigan State University
                     address:
                        name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chia-Cheng Chang
               affiliation:
                     name:College of Human Medicine, Michigan State University
                     address:
                        name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty
      description:A chemically defined culture medium was developed to support the growth of two distinctly different types of normal human breast epithelial cells (HBEC) derived from reduction mammoplasty. Type I cells expressed luminal epithelial cell markers and were deficient in gap junctional intercellular communication (GJIC), whereas Type II cells expressed basal epithelial cell markers and were efficient in GJIC. In this study, we examined and compared the growth factor and hormone requirements of these two types of cells and a series of cell lines that were obtained by sequential transfection with SV40 DNA (extended lifespan, nontumorigenic), treatment with 5-bromodeoxyuridine (BrdU)/black light (immortal and weakly tumorigenic), and infection of a virus carrying the neu oncogene (highly tumorigenic). Growth of Type I cells was inhibited by withdrawing epidermal growth factor (EGF), hydrocortisone (HC), or insulin (INS) from the culture media, but was enhanced by fetal bovine serum (FBS) supplementation. Growth of Type II cells was inhibited by withdrawal of EGF, HC, or INS from the media, and was inhibited by FBS supplementation. Withdrawal of human transferrin (HT) or 17β-estradiol (E2) from the media did not alter the growth of Type I or Type II cells. SV40 transfected Type I cell lines still required EGF, HC, or INS for optimal growth. However, the highly tumorigenic cell line did not show a growth dependence on EGF, HC, or INS but did appear to require HT and 3,3′,5-triiodo-D.L. thyronine (T3) for optimal growth. In addition, FBS stimulated the growth of these cell lines. Thus, this study shows that Type I HBEC are distinctly different from Type II HBEC in growth response to FBS and that neoplastically transformed Type I cells could become growth factor and hormone independent.
      datePublished:
      dateModified:
      pageStart:282
      pageEnd:288
      sameAs:https://doi.org/10.1007/s11626-997-0048-8
      keywords:
         growth factors
         hormones
         differential serum response
         Cell Biology
         Developmental Biology
         Stem Cells
         Cell Culture
         Animal Genetics and Genomics
      image:
      isPartOf:
         name:In Vitro Cellular & Developmental Biology - Animal
         issn:
            1543-706X
            1071-2690
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Chien-Yuan Kao
            affiliation:
                  name:College of Human Medicine, Michigan State University
                  address:
                     name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cory S. Oakley
            affiliation:
                  name:College of Human Medicine, Michigan State University
                  address:
                     name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Clifford W. Welsch
            affiliation:
                  name:College of Human Medicine, Michigan State University
                  address:
                     name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chia-Cheng Chang
            affiliation:
                  name:College of Human Medicine, Michigan State University
                  address:
                     name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:In Vitro Cellular & Developmental Biology - Animal
      issn:
         1543-706X
         1071-2690
      volumeNumber:33
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:College of Human Medicine, Michigan State University
      address:
         name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
         type:PostalAddress
      name:College of Human Medicine, Michigan State University
      address:
         name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
         type:PostalAddress
      name:College of Human Medicine, Michigan State University
      address:
         name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
         type:PostalAddress
      name:College of Human Medicine, Michigan State University
      address:
         name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Chien-Yuan Kao
      affiliation:
            name:College of Human Medicine, Michigan State University
            address:
               name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
               type:PostalAddress
            type:Organization
      name:Cory S. Oakley
      affiliation:
            name:College of Human Medicine, Michigan State University
            address:
               name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
               type:PostalAddress
            type:Organization
      name:Clifford W. Welsch
      affiliation:
            name:College of Human Medicine, Michigan State University
            address:
               name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
               type:PostalAddress
            type:Organization
      name:Chia-Cheng Chang
      affiliation:
            name:College of Human Medicine, Michigan State University
            address:
               name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
      name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
      name:Department of Pharmacology/Toxicology, College of Human Medicine, Michigan State University, East Lansing
      name:Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(113)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.81s.

LINK . SPRINGER . COM {}